A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants

Inclusion Criteria: * Healthy male and female (i e, women not of childbearing potential) participants * Body Mass Index (BMI) of 18 to 32 kg\^m2 and total body weight ≥ 50 kg * Parts A, B, and D: Participants without restriction on ethnicity * Part C: Participants of Japanese ethnicity (both biological parents are ethnically Japanese) Exclusion Criteria: * Clinically significant medical, psychiatric and/or sound social reason, as determined by the investigator * Any major surgery within 3 months of study intervention administration * Participation in another clinical trial concurrent with this study Note: Other protocol-defined inclusion/exclusion criteria apply